| A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects (NCT00363142) | GlaxoSmithKline | 2006-05-01 |
| Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage (NCT00556634) | Sociedad Andaluza de Enfermedades Infecciosas | 2006-04-01 |
| Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity (NCT00340080) | GlaxoSmithKline | 2006-04-01 |
| Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS (NCT00280449) | Hamilton Health Sciences Corporation | 2006-03-01 |
| Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy (NCT00246610) | Pfizer | 2006-03-01 |
| A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules (NCT00281606) | University of California, San Diego | 2006-02-14 |
| The Use of Nutropin Depot in HIV-infected Adult Males (NCT00286676) | University of Texas Southwestern Medical Center | 2006-02-01 |
| Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA) (NCT00226434) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-01-01 |
| An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C (NCT00141284) | Pfizer | 2005-10-01 |
| Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 (NCT00142740) | University of North Carolina, Chapel Hill | 2005-10-01 |
| Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers (NCT00224900) | University of North Carolina, Chapel Hill | 2005-09-01 |
| Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment (NCT00280969) | International Medical Center of Japan | 2005-09-01 |
| Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects (NCT00320307) | GlaxoSmithKline | 2005-09-01 |
| Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus (NCT00321438) | GlaxoSmithKline | 2005-07-01 |
| Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects (NCT00197197) | GlaxoSmithKline | 2005-07-01 |
| Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects (NCT00297076) | GlaxoSmithKline | 2005-07-01 |
| Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 (NCT00123890) | GlaxoSmithKline | 2005-06-01 |
| Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study (NCT00225017) | Northwestern University | 2005-06-01 |
| A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection (NCT01064752) | University of California, San Francisco | 2005-04-01 |
| Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients (NCT00247494) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2005-04-01 |
| An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients (NCT00189930) | Bavarian Nordic | 2005-04-01 |
| TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients (NCT00110877) | Tibotec Pharmaceuticals, Ireland | 2005-04-01 |
| Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study) (NCT00120419) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2005-04-01 |
| Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth (NCT00103532) | University of North Carolina, Chapel Hill | 2005-03-01 |
| TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use (NCT00225303) | Tibotec Pharmaceuticals, Ireland | 2005-03-01 |
| Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men (NCT00131677) | Centers for Disease Control and Prevention | 2005-02-01 |
| Single DermaVir Immunization in HIV-1 Infected Patients on HAART (NCT00712530) | Genetic Immunity | 2005-01-01 |
| Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients (NCT00234910) | Abbott | 2005-01-01 |
| A New Telemedicine Approach for Chronic HIV/AIDS Patient Home Care (NCT01117675) | Hospital Clinic of Barcelona | 2005-01-01 |
| Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults (NCT00252148) | International AIDS Vaccine Initiative | 2005-01-01 |
| GW873140 In Combination With Combivir In HIV Infected Subjects (NCT00104429) | ViiV Healthcare | 2005-01-01 |
| "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects (NCT00114933) | Arribas, Jose R., M.D. | 2005-01-01 |
| Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals (NCT00168259) | The Alfred | 2004-12-01 |
| GW873140 In Combination With Kaletra In HIV Infected Subjects (NCT00102778) | ViiV Healthcare | 2004-12-01 |
| Maintaining HIV Prevention Gains in Female Adolescents (NCT00161343) | University of Rochester | 2004-12-01 |
| Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults (NCT00343941) | GlaxoSmithKline | 2004-11-01 |
| Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission (NCT00194519) | University of Washington | 2004-11-01 |
| SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function (NCT00225082) | Northwestern University | 2004-11-01 |
| Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects (NCT00096746) | Bristol-Myers Squibb | 2004-11-01 |
| GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults (NCT00257621) | ViiV Healthcare | 2004-10-01 |
| Androgen Effects in HIV-infected Women (NCT00095212) | Massachusetts General Hospital | 2004-09-01 |
| TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial (NCT00111280) | Tibotec Pharmaceuticals, Ireland | 2004-09-01 |
| Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding (NCT00158509) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-08-01 |
| A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1 (NCT00100984) | Hoffmann-La Roche | 2004-07-21 |
| A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study) (NCT00094367) | GlaxoSmithKline | 2004-07-01 |
| Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) (NCT00158457) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-06-01 |
| Typology of Adherence in Adolescents: Phase II (NCT00106678) | University of North Carolina, Chapel Hill | 2004-06-01 |
| Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen (NCT00200369) | Montefiore Medical Center | 2004-05-01 |
| KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks (NCT00085943) | GlaxoSmithKline | 2004-05-01 |
| Once Daily 3TC, Efavirenz and ddI for HIV Infection (NCT00214435) | 407 Doctors | 2004-05-01 |
| A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV (NCT00082394) | GlaxoSmithKline | 2004-04-26 |
| Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (NCT00219362) | Objectif Recherche Vaccins SIDA | 2004-04-01 |
| TMC125-C223: TMC125 in HIV-1 Infected Subjects (NCT00081978) | Tibotec Pharmaceuticals, Ireland | 2004-03-01 |
| Analysis of Genetic Factors Which May Influence the Course of HIV Infection (NCT00159068) | Deborah Rund | 2004-02-01 |
| Cohort of Patients Naive of Antiretroviral Treatment at Enrollment (NCT03137797) | ANRS, Emerging Infectious Diseases | 2004-02-01 |
| Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV (NCT00080119) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2004-02-01 |
| An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users (NCT00841477) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth (NCT00106964) | University of North Carolina, Chapel Hill | 2004-01-01 |
| Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults (NCT00249106) | International AIDS Vaccine Initiative | 2003-12-01 |
| An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects. (NCT00081588) | Tibotec Pharmaceuticals, Ireland | 2003-11-01 |
| Prognosis of Acute Coronary Syndrome in HIV-infected Patients (NCT00139958) | Saint Antoine University Hospital | 2003-11-01 |
| Effectiveness of the Diaphragm for HIV Prevention (NCT00121459) | University of California, San Francisco | 2003-09-01 |
| Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR) (NCT00158470) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-09-01 |
| Connect to Protect Partnerships for Youth Prevention Interventions: Phase II (NCT00103896) | University of North Carolina, Chapel Hill | 2003-09-01 |
| Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients (NCT00234923) | Abbott | 2003-08-01 |
| The Effect of Vitamin D and Calcium on Bone in Pediatric HIV (NCT00724178) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-07-01 |
| Engaging Care for HIV-infected Adolescent Females. (NCT00489034) | University of North Carolina, Chapel Hill | 2003-07-01 |
| Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) (NCT00242840) | ViiV Healthcare | 2003-06-01 |
| Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients (NCT00190242) | Assistance Publique - Hôpitaux de Paris | 2003-06-01 |
| Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy (NCT00147797) | Saint Antoine University Hospital | 2003-05-01 |
| Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight (NCT01335360) | Western University of Health Sciences | 2003-05-01 |
| Pravastatin and Protease Inhibitors in HIV-infected Patients (NCT00221754) | University Hospital, Bordeaux | 2003-03-01 |
| A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma (NCT00020683) | National Cancer Institute (NCI) | 2003-03-01 |
| Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States (NCT00054743) | National Institutes of Health Clinical Center (CC) | 2003-02-06 |
| A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy (NCT00053638) | GlaxoSmithKline | 2003-02-01 |
| A Novel Method to Determine HIV Incidence Among Youth (NCT00103883) | University of North Carolina, Chapel Hill | 2003-02-01 |
| Screening HIV-Infected Patients for Vaccine Studies (NCT00051519) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-01-09 |
| Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children (NCT01982396) | PENTA Foundation | 2003-01-01 |
| Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth (NCT00107029) | University of North Carolina, Chapel Hill | 2002-12-01 |
| The Adult Antiretroviral Treatment and Resistance Study (Tshepo) (NCT00197613) | Harvard School of Public Health (HSPH) | 2002-12-01 |
| Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score (NCT00234975) | AbbVie (prior sponsor, Abbott) | 2002-10-01 |
| A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients (NCT00046176) | ViiV Healthcare | 2002-08-26 |
| Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy (NCT00234962) | Abbott | 2002-08-01 |
| New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects (NCT00044577) | ViiV Healthcare | 2002-07-16 |
| Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients (NCT01227395) | Pfizer | 2002-07-01 |
| A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years (NCT00040664) | ViiV Healthcare | 2002-07-01 |
| A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia (NCT00336245) | University of Alabama at Birmingham | 2002-06-01 |
| Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure (NCT00038506) | ViiV Healthcare | 2002-03-01 |
| Glutathione and Its Precursors in HIV-Infected Patients (NCT00910442) | UPECLIN HC FM Botucatu Unesp | 2002-02-01 |
| Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection (NCT00113126) | University Hospital, Geneva | 2002-01-01 |
| Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers (NCT00027482) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-12-04 |
| Intermittent vs. Continuous HAART to Treat Chronic HIV Infection (NCT00025909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-10-01 |
| Tenofovir Disoproxil Fumarate to Treat Pediatric HIV (NCT00024986) | National Cancer Institute (NCI) | 2001-10-01 |
| Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load (NCT00025922) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-10-01 |
| Interaction Between HIV and Lymphatic Filariasis (NCT00295698) | DBL -Institute for Health Research and Development | 2001-08-01 |
| Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young Adulthood (NCT00026806) | National Cancer Institute (NCI) | 2001-07-01 |
| Structured Treatment Interruptions in Chronic HIV Infection (NCT00324103) | Istituto Superiore di Sanità | 2001-06-01 |
| Zambia Exclusive Breastfeeding Study (NCT00310726) | Boston Medical Center | 2001-05-01 |
| An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada (NCT00162188) | Bristol-Myers Squibb | 2001-05-01 |
| The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART (NCT00035893) | AIM ImmunoTech Inc. | 2001-05-01 |